États-Unis · Plateformes & données · MarketBeat

Pfizer (NYSE:PFE) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Publié par MarketBeat · États-Unis il y a 1 h

Royal Bank Of Canada raised their price objective on Pfizer from $25.00 to $28.00 and gave the stock a "sector perform" rating in a report on Wednesday.

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Pfizer (NYSE:PFE) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

À lire aussi

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

These 12 stocks are good bets to beat the 10-year Treasury over the next decade

Eversource Energy earnings on deck after Q2 miss, estimate cuts

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Sherrod Brown wins Ohio despite crypto’s costliest $63 million bet

Pfizer (NYSE:PFE) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Partager

À lire aussi

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

These 12 stocks are good bets to beat the 10-year Treasury over the next decade

Eversource Energy earnings on deck after Q2 miss, estimate cuts

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Sherrod Brown wins Ohio despite crypto’s costliest $63 million bet